Ben Strain | Executive Director, IR & Corporate Communications |
Evan Loh | CEO & Director |
Adam Woodrow | Chief Commercial Officer & VP |
Randall Brenner | SVP, Regulatory, Quality & Technical Operations |
Antonio Arce | H.C. Wainwright & Co. |
Kevin Kedra | Gabelli & Company |
Robert Hazlett | BTIG |
Xiaozhou Fan | SVB Leerink |
Greetings, and welcome to the Paratek Pharmaceuticals Fourth Quarter and Fiscal Year 2019 Earnings Call. [Operator Instructions].
It is now my pleasure to introduce your host, Ben Strain, Vice President of Investor Relations and Corporate Communications. Thank you, Mr. Strain.